May 18, 2012

Risk Factor Management Helps Prevent Migraine Attacks


The latest genetic and biological research shows that migraine is a neurological, not vascular, disorder and both acute and preventive treatments being developed target peripheral and central nervous systems, according to a prominent migraine expert addressing the American Pain Society (APS) on May 17… David Dodick, MD, professor of neurology at Mayo Clinic in Phoenix, explained in his plenary session talk that triptan medications used to treat migraine patients are designed to constrict blood vessels, which for centuries were believed to cause migraine.


Science Daily

Tags: American Pain Society, Dr. David Dodick, Mayo Clinic Arizona, migraines, Neurology, Research, Science Daily, triptan

Please sign in or register to post a reply.
Contact Us · Privacy Policy